VERONICA RUPEL: Open Payments
NPI 1366200966 · BLUFFTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 68 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $426 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $367 |
| ABBVIE INC. | 16 | $282 |
| Lilly USA, LLC | 7 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| PFIZER INC. | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, REXULTI, MOUNJARO, Kerendia, Auvelity, QULIPTA.
Industry payments across IN — which companies pay providers there.
